Physician profile
Henry Semple
NPI 1790779486
$2,522.47
in general payments reported to CMS, 2019-2025
16 companies · $661 in 2025
The $661 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $116 · 2021: $142 · 2022: $463 · 2023: $326 · 2024: $576 · 2025: $661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,564.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,563.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $486.98 | 2021-2025 | Vabysmo, Susvimo |
| Abbvie INC. | $484.92 | 2022-2025 | Ozurdex |
| Regeneron Healthcare Solutions, INC. | $376.91 | 2019-2025 | Eylea Hd, Eylea |
| Alimera Sciences, INC. | $358.74 | 2021-2024 | Yutiq, Iluvien |
| Allergan, INC. | $169.50 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $158.91 | 2019-2020 | |
| Apellis Pharmaceuticals, INC. | $122.68 | 2024 | Syfovre |
| Dutch Ophthalmic, USA | $73.04 | 2025 | Tissueblue, Eva, Combined Machine |
| Astellas Pharma US INC | $70.12 | 2025 | Izervay |
| Ani Pharmaceuticals, INC. | $64.17 | 2025 | Iluvien, Purified Cortrophin Gel, Yutiq |
| Dompe US, INC. | $54.06 | 2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $32.26 | 2020-2021 | |
| Harrow Eye, LLC | $18.94 | 2025 | |
| Sandoz INC. | $17.64 | 2024 | Cimerli |
| Aerie Pharmaceuticals, INC. | $16.89 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coherus Oncology, INC. | $16.71 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Semple listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.